info on semaglutide Benefits of GLP-1 for Weight Loss Cardiovascular Disease | Ozempic® (semaglutide)

Listening to your body is more important than ever because semaglutide can drastically change your cravings and satiety levels

In 2022, the FDA added Wegovy (semaglutide), Ozempic (semaglutide) and Mounjaro (tirzepatide) to the FDA drug shortage list, followed by Zepbound (tirzepatide) in 2024

Moderate weight loss was found to be a common side effect of the drug, and the FDA approved a different formulation of semaglutide, called Wegovy, for that purpose in 2021

You may be a good fit for Wegovy if: Youre living with obesity (BMI 30), or Youre overweight (BMI 27) and have a weight-related health condition, and Youre open to combining the medication with nutrition, physical activity, and behavioural support because Wegovy works best as part of a long-term strategy

His BPC-157 disclosure is one of the few first-person accounts from a credentialed scientist